Home | Business News | Browse by Publication | H | HIV Treatment: ALERTS!

Hyperglycemia--another Viread + Videx risk.

Publication: HIV Treatment: ALERTS!
Publication Date: 01-APR-05
Format: Online
Delivery: Immediate Online Access
Full Article Title: Hyperglycemia--another Viread + Videx risk.(The combination of the HIV needs Viread and Videx )(Brief Article)

Article Excerpt
The combination of the HIV needs Viread and Videx requires special dosing and can cause serious side effects, including drops in T cell counts, problems with the pancreas, and risk of virologic failure. A recent study (abstract 829) examined the medical charts of 177 HIV+ people, 78 of whom...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from HIV Treatment: ALERTS!
Pancreas problems.(Treatment News), April 01, 2005
Past drug use may affect T cell count.(injection drug users )(Brief Ar..., April 01, 2005
Stem cell transplants for cancer.(Treatment News), April 01, 2005
Early viral load predicts treatment success.(Treatment News)(Brief Art..., April 01, 2005
Update to HIV treatment guidelines.(Treatment News)(Brief Article), April 01, 2005

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.